Related Experiment Video
Updated: Jan 7, 2026
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel
Iolanda Valentina Popa1, Mihaela Dranga2, Otilia Nedelciuc3
1Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania. iolivp@gmail.com.
Background And Aims:
Differential diagnosis between irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) represents a major challenge in modern gastroenterology due to overlapping symptoms, limitations of traditional diagnostic methods, and the complexity of their pathophysiology. This review examines the application of artificial intelligence (AI) and machine learning (ML) methods to improve accuracy and efficiency in the differential diagnosis between IBS and IBD.
Methods:
The review encompasses seven recent studies employing various AI/ML techniques, utilizing clinical, genetic, microbiomic, and imaging data.
Results:
AI-based models exhibit high sensitivity and specificity, with remarkable performance by algorithms such as logistic regression, random forest, neural networks, and support vector machines. Highlighted biomarkers include long non-coding RNA molecules, DNA methylation profiles, and diverse compounds from gut microbiota.
Conclusions:
Although AI/ML methods show significant potential for distinguishing IBS from IBD, existing studies present limitations, including small sample sizes, data heterogeneity, and generalizability challenges. The development of standardized protocols and extensive multicenter studies is recommended to clinically validate these models, facilitating their integration into current medical practice.
Related Concept Videos
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...